NCT01543152: A trial that was reported late by Sangamo Therapeutics
This trial has reported, although it was 992 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01543152 |
|---|---|
| Title | A Phase I, Open-Label Study to Assess the Effect of Escalating Doses of Cyclophosphamide on the Engraftment of SB-728-T in Aviremic HIV-Infected Subjects on HAART |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 31, 2011 |
| Completion date | July 7, 2017 |
| Required reporting date | July 7, 2018, midnight |
| Actual reporting date | March 25, 2021 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 992 |